Literature DB >> 10379911

Interleukin-7: physiological roles and mechanisms of action.

R Hofmeister1, A R Khaled, N Benbernou, E Rajnavolgyi, K Muegge, S K Durum.   

Abstract

Interleukin-7 (IL-7), a product of stromal cells, provides critical signals to lymphoid cells at early stages in their development. Two types of cellular responses to IL-7 have been identified in lymphoid progenitors: (1) a trophic effect and (2) an effect supporting V(D)J recombination. The IL-7 receptor is comprised of two chains, IL-7R alpha and gamma(c). Following receptor crosslinking, rapid activation of several classes of kinases occurs, including members of the Janus and Src families and PI3-kinase. A number of transcription factors are subsequently activated including STATs, c-myc, NFAT and AP-1. However, it remains to be determined which, if any, previously identified pathway leads to the trophic or V(D)J endpoints. The trophic response to IL-7 involves protecting lymphoid progenitors from a death process that resembles apoptosis. This protection is partly mediated by IL-7 induction of Bcl-2, however other IL-7-induced events are probably also involved in the trophic response. The V(D)J response to IL-7 is partly mediated through increased production of Rag proteins (which cleave the target locus) and partly by increasing the accessibility of a target locus to cleavage through chromatin remodeling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10379911     DOI: 10.1016/s1359-6101(98)00025-2

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  54 in total

1.  Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH.

Authors:  A R Khaled; K Kim; R Hofmeister; K Muegge; S K Durum
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy.

Authors:  E C Darcissac; V Vidal; X De La Tribonniere; Y Mouton; G M Bahr
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

3.  Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency.

Authors:  M Neale Weitzmann; Cristiana Roggia; Gianluca Toraldo; Louise Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

4.  Controlled major histocompatibility complex-T cell receptor signaling allows efficient generation of functional, antigen-specific CD8+ T cells from embryonic stem cells and thymic progenitors.

Authors:  Jian Lin; Hui Nie; Phillip W Tucker; Krishnendu Roy
Journal:  Tissue Eng Part A       Date:  2010-09       Impact factor: 3.845

5.  Effects of lymphocyte isolation and timing of processing on detection of CD127 expression on T cells in human immunodeficiency virus-infected patients.

Authors:  Jeanette Higgins; Julia A Metcalf; Randy A Stevens; Michael Baseler; Martha C Nason; H Clifford Lane; Irini Sereti
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

6.  TGF-β inhibits IL-7-induced proliferation in memory but not naive human CD4+ T cells.

Authors:  Thao P Nguyen; Scott F Sieg
Journal:  J Leukoc Biol       Date:  2017-06-06       Impact factor: 4.962

7.  Interleukin-7 enhances memory CD8(+) T-cell recall responses in health but its activity is impaired in human immunodeficiency virus infection.

Authors:  Alison M O'Connor; Angela M Crawley; Jonathan B Angel
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

Review 8.  TSLP in epithelial cell and dendritic cell cross talk.

Authors:  Yong-Jun Liu
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

9.  Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization.

Authors:  A R Khaled; A N Moor; A Li; K Kim; D K Ferris; K Muegge; R J Fisher; L Fliegel; S K Durum
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.

Authors:  Valerie I Brown; Junjie Fang; Keith Alcorn; Rosalind Barr; Jenny M Kim; Robert Wasserman; Stephan A Grupp
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.